Anniina Färkkilä
@afarkkila.bsky.social
Assistant (TT) Professor in Translational #gynoncology, Clinician scientist📍University of Helsinki 🇫🇮 Passionate about #precisiononcology #spatialbiology #leadership 🔗 www.farkkilab.org
Was a great honour to host Iain McNeish on World Ovarian Cancer Day! And huge congratulations to my student Fernando Perez-Villatoro for successfully defending his PhD #wocd #proudsupervisor @farkkilab.bsky.social @helsinki.fi
May 10, 2025 at 6:30 AM
Was a great honour to host Iain McNeish on World Ovarian Cancer Day! And huge congratulations to my student Fernando Perez-Villatoro for successfully defending his PhD #wocd #proudsupervisor @farkkilab.bsky.social @helsinki.fi
Thank you #AACR25!
Was a great hobour to be nominated as a NextGen Star, and give a talk! 🤩 In addition to great science, I particularly enjoyed meeting new people and networking! 👌🏻😍
Was a great hobour to be nominated as a NextGen Star, and give a talk! 🤩 In addition to great science, I particularly enjoyed meeting new people and networking! 👌🏻😍
April 30, 2025 at 12:12 AM
Thank you #AACR25!
Was a great hobour to be nominated as a NextGen Star, and give a talk! 🤩 In addition to great science, I particularly enjoyed meeting new people and networking! 👌🏻😍
Was a great hobour to be nominated as a NextGen Star, and give a talk! 🤩 In addition to great science, I particularly enjoyed meeting new people and networking! 👌🏻😍
Our recent publication highlighted 🎉 acir.org/journal-arti...
Immune cell biology - ACIR Journal Articles
The latest advances in cancer immunotherapy.
acir.org
December 19, 2024 at 7:01 AM
Our recent publication highlighted 🎉 acir.org/journal-arti...
Reposted by Anniina Färkkilä
Research led by @afarkkila.bsky.social and @anna-vaharautio.bsky.social from 🇫🇮 @helsinkiuni.bsky.social offers new insights into harnessing the immune system to combat #ovariancancer. The findings could lead to personalized therapies that target the right patients at the right time.
How chemotherapy affects ovarian cancer tumours
Researchers have discovered how chemotherapy can change tumours, making them more vulnerable to new types of treatments.
dlvr.it
December 15, 2024 at 7:31 AM
Research led by @afarkkila.bsky.social and @anna-vaharautio.bsky.social from 🇫🇮 @helsinkiuni.bsky.social offers new insights into harnessing the immune system to combat #ovariancancer. The findings could lead to personalized therapies that target the right patients at the right time.
Excited to join the ESSB!
@afarkkila.bsky.social, Sara, Ada, and Aleksandra are representing the lab at ESSB in Berlin!
Find them to discuss spatial biology!
🟠 Poster #88: Ada presents a spatial study of the cell cycle in #HGSC
🟠 Poster #155: Aleksandra showcases the use of ML to uncover spatial tumor ecosystems
Find them to discuss spatial biology!
🟠 Poster #88: Ada presents a spatial study of the cell cycle in #HGSC
🟠 Poster #155: Aleksandra showcases the use of ML to uncover spatial tumor ecosystems
December 12, 2024 at 1:59 PM
Excited to join the ESSB!
We uncover how standard of care chemotherapy shapes the tumor microenvironment ➡️ #spatialbiology #ovariancancer
1/n New paper alert 🚨 We're thrilled to share our just published paper in #CancerCell
Do you ever wonder how the #TME in #HGSC changes during chemotherapy? Check it here: www.sciencedirect.com/science/arti... and let’s dive into the highlights together #spatialbiology #ovariancancer #cancerresarch
Do you ever wonder how the #TME in #HGSC changes during chemotherapy? Check it here: www.sciencedirect.com/science/arti... and let’s dive into the highlights together #spatialbiology #ovariancancer #cancerresarch
Chemotherapy induces myeloid-driven spatially confined T cell exhaustion in ovarian cancer
Anti-tumor immunity is crucial for high-grade serous ovarian cancer (HGSC) prognosis, yet its adaptation upon standard chemotherapy remains poorly und…
www.sciencedirect.com
December 10, 2024 at 3:28 PM
We uncover how standard of care chemotherapy shapes the tumor microenvironment ➡️ #spatialbiology #ovariancancer
Reposted by Anniina Färkkilä
Researchers @helsinkiuni.bsky.social have discovered how chemotherapy can change tumors, making them more vulnerable to new types of treatments.
The findings from @afarkkila.bsky.social & @Vähärautio groups could lead to personalised therapies, offering hope for improving care for ovarian cancer.
The findings from @afarkkila.bsky.social & @Vähärautio groups could lead to personalised therapies, offering hope for improving care for ovarian cancer.
New insights into harnessing the immune system to combat ovarian cancer | University of Helsinki
Researchers have discovered how chemotherapy can change tumors, making them more vulnerable to new types of treatments. These findings could lead to personalized therapies that target the right patien...
www.helsinki.fi
December 10, 2024 at 11:45 AM
Researchers @helsinkiuni.bsky.social have discovered how chemotherapy can change tumors, making them more vulnerable to new types of treatments.
The findings from @afarkkila.bsky.social & @Vähärautio groups could lead to personalised therapies, offering hope for improving care for ovarian cancer.
The findings from @afarkkila.bsky.social & @Vähärautio groups could lead to personalised therapies, offering hope for improving care for ovarian cancer.
Really happy to share our new publication! @anna-vaharautio.bsky.social Stay tuned for more insights! @farkkilab.bsky.social www.helsinki.fi/en/news/canc...
New insights into harnessing the immune system to combat ovarian cancer | University of Helsinki
Researchers have discovered how chemotherapy can change tumors, making them more vulnerable to new types of treatments. These findings could lead to personalized therapies that target the right patien...
www.helsinki.fi
December 10, 2024 at 7:36 AM
Really happy to share our new publication! @anna-vaharautio.bsky.social Stay tuned for more insights! @farkkilab.bsky.social www.helsinki.fi/en/news/canc...
New preprint alert ‼️ @farkkilab.bsky.social We generated a single-cell spatial atlas of 280 metastatic #ovariancancer and found tumor MHCII as a key driver of tumor ecosystems and clinical outcomes. www.biorxiv.org/content/10.1...
Single-cell spatial atlas of high-grade serous ovarian cancer unveils MHC class II as a key driver of spatial tumor ecosystems and clinical outcomes
The tumor microenvironment (TME) is a complex network of interactions between malignant and host cells, yet its orchestration in advanced high-grade serous ovarian carcinoma (HGSC) remains poorly unde...
www.biorxiv.org
December 4, 2024 at 5:33 AM
New preprint alert ‼️ @farkkilab.bsky.social We generated a single-cell spatial atlas of 280 metastatic #ovariancancer and found tumor MHCII as a key driver of tumor ecosystems and clinical outcomes. www.biorxiv.org/content/10.1...
New paper published! We modelled PARPi maintenance therapy in #ovariancancer www.nature.com/articles/s41...
Mathematical modeling framework enhances clinical trial design for maintenance treatment in oncology - Scientific Reports
Scientific Reports - Mathematical modeling framework enhances clinical trial design for maintenance treatment in oncology
www.nature.com
November 29, 2024 at 4:58 PM
New paper published! We modelled PARPi maintenance therapy in #ovariancancer www.nature.com/articles/s41...
Matilda presenting her PhD work at NSGO Annual meeting 🎉💪🏼 #ovariancancer #clinicalcancerresrarch @farkkilab.bsky.social
November 28, 2024 at 10:43 AM
Matilda presenting her PhD work at NSGO Annual meeting 🎉💪🏼 #ovariancancer #clinicalcancerresrarch @farkkilab.bsky.social
Congrats Antti &co from thw Nykter Lab 🎉
Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer.
doi.org/10.1038/s414...
doi.org/10.1038/s414...
Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer - Nature Communications
The prostate cancer tumour microenvironment in the context of treatment remains to be explored. Here, single-cell RNA-sequencing and spatial transcriptomics analysis of samples at multiple treatment p...
doi.org
November 24, 2024 at 11:42 AM
Congrats Antti &co from thw Nykter Lab 🎉
Hello Bluesky 👋 We
are #hiring; Calling all aspiring #postdoc s: passionate about #spatialbiology, #proteomics, and the #TME? Join our multidisciplinary team in 🇫🇮 to make impactful discoveries in #ovariancancer
🧬 farkkilab.org/careers/job-ads
Sharing appreciated🤗
are #hiring; Calling all aspiring #postdoc s: passionate about #spatialbiology, #proteomics, and the #TME? Join our multidisciplinary team in 🇫🇮 to make impactful discoveries in #ovariancancer
🧬 farkkilab.org/careers/job-ads
Sharing appreciated🤗
Job ads – Farkkila lab
farkkilab.org
November 23, 2024 at 8:23 PM
Hello Bluesky 👋 We
are #hiring; Calling all aspiring #postdoc s: passionate about #spatialbiology, #proteomics, and the #TME? Join our multidisciplinary team in 🇫🇮 to make impactful discoveries in #ovariancancer
🧬 farkkilab.org/careers/job-ads
Sharing appreciated🤗
are #hiring; Calling all aspiring #postdoc s: passionate about #spatialbiology, #proteomics, and the #TME? Join our multidisciplinary team in 🇫🇮 to make impactful discoveries in #ovariancancer
🧬 farkkilab.org/careers/job-ads
Sharing appreciated🤗